These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3430510)

  • 1. High levels of fibronectin fragments in the plasma of a patient with active systemic lupus erythematosus.
    Carsons S
    J Rheumatol; 1987 Oct; 14(5):1052-4. PubMed ID: 3430510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma fibronectin in systemic lupus erythematosus: relationship to clinical activity, DNA binding and acute phase proteins.
    Carsons S; Parenti D; Lavietes BB; Diamond HS; Singer A; Boxer M
    J Rheumatol; 1985 Dec; 12(6):1088-92. PubMed ID: 2419557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
    Manzi S; Navratil JS; Ruffing MJ; Liu CC; Danchenko N; Nilson SE; Krishnaswami S; King DE; Kao AH; Ahearn JM
    Arthritis Rheum; 2004 Nov; 50(11):3596-604. PubMed ID: 15529364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet C4d is highly specific for systemic lupus erythematosus.
    Navratil JS; Manzi S; Kao AH; Krishnaswami S; Liu CC; Ruffing MJ; Shaw PS; Nilson AC; Dryden ER; Johnson JJ; Ahearn JM
    Arthritis Rheum; 2006 Feb; 54(2):670-4. PubMed ID: 16447243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
    Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
    Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies.
    Castellino G; Corallini F; Trotta F; Secchiero P
    Lupus; 2007; 16(7):479-82. PubMed ID: 17670845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.
    Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR
    Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus.
    Nezlin R; Alarcón-Segovia D; Shoenfeld Y
    J Autoimmun; 1998 Oct; 11(5):489-93. PubMed ID: 9802934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDN-21 in premenopausal women with systemic lupus erythematosus treated with glucocorticoids.
    Navarro MA; Formiga F; Blanco A; Bonnin MR; Nolla JM; Moga I
    J Rheumatol; 1995 Dec; 22(12):2238-40. PubMed ID: 8835555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin binds to C1q: possible mechanisms for their co-precipitation in cryoglobulins from patients with systemic lupus erythematosus.
    Kono I; Sakurai T; Kabashima T; Yamane K; Kashiwagi H
    Clin Exp Immunol; 1983 May; 52(2):305-10. PubMed ID: 6602675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of fibronectin and granulocyte elastase in plasma of patients with systemic connective-tissue diseases.
    Schneider M; Lohmann J; Krummenerl T; Gerlach U
    Int J Tissue React; 1987; 9(4):355-9. PubMed ID: 3497902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
    Singh V; Mahoney JA; Petri M
    J Rheumatol; 2008 Oct; 35(10):1989-93. PubMed ID: 18709693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus.
    Jacobi AM; Odendahl M; Reiter K; Bruns A; Burmester GR; Radbruch A; Valet G; Lipsky PE; Dörner T
    Arthritis Rheum; 2003 May; 48(5):1332-42. PubMed ID: 12746906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus.
    Cruz J; Aviña-Zubieta A; Martínez de la Escalera G; Clapp C; Lavalle C
    Arthritis Rheum; 2001 Jun; 44(6):1331-5. PubMed ID: 11407692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of fibronectin in plasma and synovial fluid from patients with rheumatoid arthritis and systemic lupus erythematosus ].
    Matsumoto Y; Imaizumi T; Kanie R
    Ryumachi; 1982 Jun; 22(3):240-3. PubMed ID: 7123399
    [No Abstract]   [Full Text] [Related]  

  • 17. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent increase in plasma thrombomodulin in patients with a history of lupus nephritis: endothelial cell activation markers.
    Frijns R; Fijnheer R; Schiel A; Donders R; Sixma J; Derksen R
    J Rheumatol; 2001 Mar; 28(3):514-9. PubMed ID: 11296951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus.
    Liu CC; Manzi S; Kao AH; Navratil JS; Ruffing MJ; Ahearn JM
    Arthritis Rheum; 2005 Oct; 52(10):3087-99. PubMed ID: 16200588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of plasma levels of soluble CD40 ligand in systemic lupus erythematosus patients who have undergone plasmapheresis.
    Kimura K; Tsuda H; Kwangseok Y; Tamura N; Kanai Y; Kobayashi S
    Ther Apher Dial; 2005 Feb; 9(1):64-8. PubMed ID: 15828909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.